Nonoperative management of rectal cancer
- 期刊名称Cancer
- 作者Torok, Jordan A.; Palta, Manisha; Willett, Christopher G.; Czito, Brian G.
- 卷第122卷
- 期第1期
- 印刷ISSN0008-543X
- 文件大小112.75KB
- 发表时间2016-01-01
- DOI10.1002/cncr.29735
- 页码34-41
Amantadine Monotherapy Is Ineffective in the Treatment of Hepatitis C Virus Recurrence in the Post-Liver Transplantation SettingF. Muzi; G. Orlando; B. Ielpo; A. Anselmo; S. Sabato Ceraldi; N. de’Liguori Carino; T. Manzia; D. D’Andria; L. Tariciotti; M. Angelico; G. Tisone · 2005
Treatment of Patients With Hepatitis C Virus infection (Genotype 4) With Ledipasvir-Sofosbuvir in the Liver Transplant SettingAbaalkhail, Faisal; Elsiesy, Hussein; Elbeshbeshy, Hany; Shawkat, Mohamed; Yousif, Sarra; Ullah, Waheed; Alabbad, Saleh; Al-jedai, Ahmed; Ajlan, Aziza; Broering, Dieter; Saab, Sammy; Al Sebayel, Mohammed; Al-Hamoudi, Waleed · Transplantation · 2017
Course of hepatitis C virus (HCV) RNA and HCV core antigen testing are predictors for reaching sustained virologic response in liver transplant recipients undergoing sofosbuvir treatment in a real-life settingPischke, S.; Polywka, S.; Proske, V.M.; Lang, M.; Jordan, S.; Nashan, B.; Lohse, A.W.; Sterneck, M. · Transplant Infectious Disease · 2016
ReplyGutierrez, Julio A.; Carrion, Andres; Bhamidimarri, Kalyan Ram; Peyton, Adam L. · Liver Transplantation · 2015
Sofosbuvir and simeprevir for treatment of hepatitis C virus infection in liver transplant recipientsGutierrez, Julio A.; Carrion, Andres F.; Avalos, Danny; O'Brien, Christopher; Martin, Paul; Bhamidimarri, Kalyan Ram; Peyton, Adam · Liver Transplantation · 2015
Safety, efficacy and tolerability of half-dose sofosbuvir plus simeprevir in treatment of Hepatitis C in patients with end stage renal diseaseKalyan Ram, Bhamidimarri; Frank, Czul; Adam, Peyton; Cynthia, Levy; Maria, Hernandez; Lennox, Jeffers; David, Roth; Eugene, Schiff; Christopher, O’Brien; Paul, Martin · Journal of Hepatology · 2015
Corrigendum to “Safety, efficacy and tolerability of half-dose sofosbuvir plus simeprevir in treatment of Hepatitis C in patients with end stage renal disease” [J Hepatol 2015;63:763–765]Bhamidimarri, Kalyan Ram; Czul, Frank; Peyton, Adam; Levy, Cynthia; Hernandez, Maria; Jeffers, Lennox; Roth, David; Schiff, Eugene; O’Brien, Christopher; Martin, Paul · Journal of Hepatology · 2015
Screening for esophageal varicesLemoinne, Sara; Thabut, Dominique · Clinical Liver Disease · 2012
Risk factors for hepatocellular carcinomaHerbst, D. Alan; Reddy, K. Rajender · Clinical Liver Disease · 2012
Radiological diagnosis of hepatocellular carcinomaRusso, Mark W.; Wald, Christoph · Clinical Liver Disease · 2012
Molecular epidemiology of hepatocellular carcinomaHoshida, Yujin · Clinical Liver Disease · 2012
Systemic targeted therapy beyond sorafenibCabrera, Roniel · Clinical Liver Disease · 2012
Portal hypertension in childrenLing, Simon C. · Clinical Liver Disease · 2012
Management of gastric varicesWong Kee Song, Louis M. · Clinical Liver Disease · 2012
Ectopic varicesSarin, Shiv Kumar; Kumar, Chandan K. N. · Clinical Liver Disease · 2012